age-related macular degeneration

Healthcare provider and patient with an orange shirt sitting at a desk and looking at a tablet

iHealthScreen submits AI-enabled eye screening system for 510(k) clearance

By Jessica Hagen 11:47 am May 25, 2023

Editor's note: This article has been updated to reflect iHealthScreen has submitted but not yet received 510(k) clearance for iPredict. iHealthScreen, maker of AI-enabled software for retinal imaging, has submitted its iPredict Eye Screening System, which leverages AI to help providers determine if a patient over 50 has age-related macular degeneration, for FDA 510(k) clearance. The iPredict...

Diabetic Macular Edema, Alleye, age-related macular degeneration, bayer

Bayer Middle East brings Alleye home monitoring programme to Egypt

By Ahmed El Sherif 04:32 am September 3, 2021

Bayer Middle East has introduced its Alleye Home Monitoring Sponsorship Programme to the Egyptian healthcare sector, it has been confirmed. The global pharma giant is reportedly working with some of the country’s top-rated eye hospitals to “support Egypt’s ophthalmologists in the new era” of virtual care for patients with either Diabetic Macular Edema [DME] – a complication of diabetic...